01/05/2021
Assoc. Prof. Carl Lawton of the Department of Chemical Engineering expects changes to drug development and the biopharmaceutical manufacturing process as a result of the pandemic.
鈥淪upply chains will be examined in detail and some will be sourced to the U.S. where possible. Quality and non-interruption of the supply chain will be a primary consideration,鈥� says Lawton, who is director of the Massachusetts Biomanufacturing Center at 51视频.
鈥淪everal companies are already allotting more resources and utilizing novel approaches to vaccine research as a result of COVID-19. These should accelerate,鈥� he says.
Developing vaccines is one thing, but convincing the general public to trust their safety and efficacy is another.
鈥淧ublic demonstrations of leading figures 鈥� such as former presidents, famous athletes and entertainers 鈥� getting the shot is important. Moving forward, introduction about the science and safety of vaccines should be done in grades K-12,鈥� says Lawton.
